Cancer-like Hallmarks of Endometriosis: The Role of Estrogen Signaling and Stem Cell Plasticity
International Journal of Molecular Sciences · 18.05.2026 · 27 (10) · 4510
DOI: 10.3390/ijms27104510 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.05.2026. Verfasst von Pietro Giulio Signorile und 4 weiteren Autor:innen. Beteiligte Einrichtung: Italian Endometriosis Foundation, 00197 Rome, Italy. Hauptthemen laut MEDLINE: Endometriosis, Estrogens, Signal Transduction, Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Italiana Endometriosi.
Abstract (Originalsprache)
Endometriosis is a chronic estrogen-dependent inflammatory disease affecting approximately 10% of women of reproductive age and characterized by ectopic endometrial-like tissue growth. Although traditionally considered a benign gynecological condition, increasing evidence indicates that endometriosis shares several molecular and cellular features with malignant processes, including enhanced proliferation, resistance to apoptosis, invasive behavior, and the ability to remodel the surrounding microenvironment. Recent studies suggest that dysregulated estrogen signaling, particularly the imbalance between estrogen receptor subtypes, plays a central role in driving these processes and may contribute to the persistence and progression of ectopic lesions. In parallel, also the involvement of stem or progenitor cells has been highly investigated because they may support lesion establishment, cellular plasticity, and long-term disease maintenance. These mechanisms overlap with pathways commonly involved in tumor initiation and progression. Recognizing endometriosis as a stem cell-driven and estrogen-dependent condition, the perspective, in both clinical management and therapeutic strategies fields, can change. Indeed, it is essential to emphasize that endometriosis is a benign condition and that the risk of developing an associated tumor is very low, approximately 1.5–2%. This review aims to discuss current evidence on the molecular aspects, focusing on estrogen signaling, stem cell-related mechanisms, and inflammatory and microenvironmental pathways that contribute to disease development. By highlighting these mechanisms, an integrated perspective on the pathophysiology of endometriosis is provided, also to outline potential implications for biomarker discovery and targeted therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Italian Endometriosis Foundation, 00197 Rome, Italy.
- Department of Life Science, Health and Health Professions, Link Campus University, 00165 Rome, Italy.
- Unit of Pathology, Monaldi Hospital, A.O. dei Colli, 80131 Naples, Italy.
ORCID-Profile: Alfonso Baldi, Manuela Montanaro, Mariarosaria Boccellino
Förderung
- Fondazione Italiana Endometriosi
Zitieren
APA
Signorile, P. G., Baldi, A., Mazzotti, A., Montanaro, M., & Boccellino, M. (2026). Cancer-like Hallmarks of Endometriosis: The Role of Estrogen Signaling and Stem Cell Plasticity. International Journal of Molecular Sciences, 27(10), 4510. https://doi.org/10.3390/ijms27104510
Vancouver
Signorile PG, Baldi A, Mazzotti A, Montanaro M, Boccellino M. Cancer-like Hallmarks of Endometriosis: The Role of Estrogen Signaling and Stem Cell Plasticity. International Journal of Molecular Sciences. 2026;27(10):4510. doi:10.3390/ijms27104510
BibTeX
@article{Signorile2026,
author = {Signorile, Pietro Giulio and Baldi, Alfonso and Mazzotti, Antonella and Montanaro, Manuela and Boccellino, Mariarosaria},
title = {Cancer-like Hallmarks of Endometriosis: The Role of Estrogen Signaling and Stem Cell Plasticity},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {10},
pages = {4510},
doi = {10.3390/ijms27104510}
}
EUVIMED